Learn more about MedInsight in our latest resources
Featured Resources
2024 Insights: Key trends reshaping healthcare analytics
As we prepare for the new year, the healthcare industry has been propelled forward by remarkable advancements in Generative AI (Gen AI), value-based care (VBC), and the electronic health record (EHR) data integration. While the overall goal of improving patient care has remained on track over the years, the introduction of Gen AI is revolutionizing … 2024 Insights: Key trends reshaping healthcare analytics
Supercharging healthcare analysis with robust provider data
Organizations in and around the healthcare industry are clamoring for more data and more data-driven insights to guide their decisions. At their core, many of these decisions rely on an understanding of the overall healthcare system. Understanding the healthcare system in turn requires an understanding of healthcare providers working in the system, as well as … Supercharging healthcare analysis with robust provider data
Navigating risk and revenue growth: A CFO’s guide to value-based contracts
As healthcare reimbursement models shift towards value-based care (VBC), chief financial officers (CFOs) are increasingly at the forefront of managing the financial implications of these changes. Not only are CFOs instrumental in assessing and mitigating the risks associated with new contracting models, but they are also responsible for ensuring that their organizations can thrive in … Navigating risk and revenue growth: A CFO’s guide to value-based contracts
Exploring the provider landscape in Sickle Cell Disease through a gene therapy lens
Sickle Cell Disease (SCD) is one of the most common genetic disorders in the world. The disease has significant impacts on quality of life and life expectancy for racial and ethnic minorities in the United States. Breakthrough, potentially curative gene therapy treatments have recently been developed and approved but remain costly and difficult to provide … Exploring the provider landscape in Sickle Cell Disease through a gene therapy lens
Increased spending on low-value care during the COVID-19 pandemic in Virginia
The U.S. spends more money on healthcare than other countries without commensurate improvement in health outcomes. Part of this wasteful spending is attributed to low-value care, services for clinical scenarios that lack evidence and therefore do not benefit health, raise costs, and sometimes cause patient harm. Examples are cardiovascular screening tests for asymptomatic low-risk patients … Increased spending on low-value care during the COVID-19 pandemic in Virginia
The power of insight: Enhancing VBC contract management and outcomes with analytics
The transition towards value-based care (VBC) is rapidly reshaping the healthcare landscape. While this shift holds immense promise for improving patient outcomes and reducing costs, it also presents a unique set of challenges that demand careful consideration for successful contract negotiations and management. In this blog post Milliman MedInsight product manager, Umang Gupta, explains the … The power of insight: Enhancing VBC contract management and outcomes with analytics
Browse our full library of resources
All resources
Advancing patient care through data integration
In this video, Southeastern Health Partners CEO, Keith Newnam, and IT Consultant, Dino Capone, discuss the benefits of their collaboration with Milliman MedInsight. They explain how the partnership addresses data challenges and enhances patient care by integrating innovative data strategies. For more information, read our case study here.
Navigating risk and revenue growth: A CFO’s guide to value-based contracts
As healthcare reimbursement models shift towards value-based care (VBC), chief financial officers (CFOs) are increasingly at the forefront of managing the financial implications of these changes. Not only are CFOs instrumental in assessing and mitigating the risks associated with new contracting models, but they are also responsible for ensuring that their organizations can thrive in … Navigating risk and revenue growth: A CFO’s guide to value-based contracts
Exploring the provider landscape in Sickle Cell Disease through a gene therapy lens
Sickle Cell Disease (SCD) is one of the most common genetic disorders in the world. The disease has significant impacts on quality of life and life expectancy for racial and ethnic minorities in the United States. Breakthrough, potentially curative gene therapy treatments have recently been developed and approved but remain costly and difficult to provide … Exploring the provider landscape in Sickle Cell Disease through a gene therapy lens
Increased spending on low-value care during the COVID-19 pandemic in Virginia
The U.S. spends more money on healthcare than other countries without commensurate improvement in health outcomes. Part of this wasteful spending is attributed to low-value care, services for clinical scenarios that lack evidence and therefore do not benefit health, raise costs, and sometimes cause patient harm. Examples are cardiovascular screening tests for asymptomatic low-risk patients … Increased spending on low-value care during the COVID-19 pandemic in Virginia
The power of insight: Enhancing VBC contract management and outcomes with analytics
The transition towards value-based care (VBC) is rapidly reshaping the healthcare landscape. While this shift holds immense promise for improving patient outcomes and reducing costs, it also presents a unique set of challenges that demand careful consideration for successful contract negotiations and management. In this blog post Milliman MedInsight product manager, Umang Gupta, explains the … The power of insight: Enhancing VBC contract management and outcomes with analytics
